Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.96 INR | +4.78% |
|
+6.58% | +29.61% |
Valuation
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 54.17 | 44.65 | 17.8 | 72.63 | 229.2 | 238.9 |
Enterprise Value (EV) 1 | 101.7 | 96.16 | 62.04 | 122.5 | 348 | 328 |
P/E ratio | 17.7 x | 6.82 x | 42.7 x | 142 x | 1,283 x | 6.24 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.14 x | 0.15 x | 0.06 x | 0.12 x | 0.24 x | 0.13 x |
EV / Revenue | 0.26 x | 0.33 x | 0.2 x | 0.2 x | 0.36 x | 0.18 x |
EV / EBITDA | 11.5 x | 7.59 x | 9.4 x | 17.9 x | -328 x | 11.1 x |
EV / FCF | 6.37 x | -15.5 x | 9.43 x | -19 x | -4.68 x | 71.1 x |
FCF Yield | 15.7% | -6.44% | 10.6% | -5.26% | -21.3% | 1.41% |
Price to Book | 0.47 x | 0.36 x | 0.14 x | 0.59 x | 1.85 x | 1.47 x |
Nbr of stocks (in thousands) | 5,953 | 5,953 | 5,953 | 5,953 | 5,953 | 5,953 |
Reference price 2 | 9.100 | 7.500 | 2.990 | 12.20 | 38.50 | 40.13 |
Announcement Date | 9/4/18 | 9/5/19 | 8/6/20 | 8/6/21 | 7/6/22 | 9/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 385.8 | 289.5 | 302.8 | 609.1 | 959.2 | 1,819 |
EBITDA 1 | 8.839 | 12.67 | 6.597 | 6.853 | -1.06 | 29.63 |
EBIT 1 | 7.358 | 11.04 | 4.896 | 5.262 | -2.709 | 27.99 |
Operating Margin | 1.91% | 3.81% | 1.62% | 0.86% | -0.28% | 1.54% |
Earnings before Tax (EBT) 1 | 2.439 | 6.025 | 1.042 | 1.141 | 0.4236 | 54.28 |
Net income 1 | 3.063 | 6.553 | 0.4446 | 0.5112 | 0.1921 | 38.28 |
Net margin | 0.79% | 2.26% | 0.15% | 0.08% | 0.02% | 2.1% |
EPS 2 | 0.5145 | 1.100 | 0.0700 | 0.0859 | 0.0300 | 6.430 |
Free Cash Flow 1 | 15.97 | -6.195 | 6.581 | -6.442 | -74.3 | 4.614 |
FCF margin | 4.14% | -2.14% | 2.17% | -1.06% | -7.75% | 0.25% |
FCF Conversion (EBITDA) | 180.66% | - | 99.76% | - | - | 15.57% |
FCF Conversion (Net income) | 521.34% | - | 1,480.38% | - | - | 12.05% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/4/18 | 9/5/19 | 8/6/20 | 8/6/21 | 7/6/22 | 9/6/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 47.6 | 51.5 | 44.2 | 49.9 | 119 | 89.1 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 5.38 x | 4.067 x | 6.706 x | 7.281 x | -112.1 x | 3.007 x |
Free Cash Flow 1 | 16 | -6.19 | 6.58 | -6.44 | -74.3 | 4.61 |
ROE (net income / shareholders' equity) | 2.67% | 5.49% | 0.36% | 0.42% | 0.16% | 26.8% |
ROA (Net income/ Total Assets) | 2.42% | 3.73% | 1.59% | 1.69% | -0.71% | 5.87% |
Assets 1 | 126.3 | 175.8 | 28.01 | 30.34 | -27.13 | 651.6 |
Book Value Per Share 2 | 19.50 | 20.60 | 20.70 | 20.70 | 20.80 | 27.20 |
Cash Flow per Share 2 | 0.0400 | 0.0200 | 0.0400 | 0.0600 | 0.0200 | 0.0100 |
Capex 1 | 2.88 | 1.14 | 3.2 | 1.01 | 0.79 | 0.53 |
Capex / Sales | 0.75% | 0.39% | 1.06% | 0.17% | 0.08% | 0.03% |
Announcement Date | 9/4/18 | 9/5/19 | 8/6/20 | 8/6/21 | 7/6/22 | 9/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+29.61% | 6.73M | |
-4.67% | 269B | |
+0.31% | 40.43B | |
-13.22% | 38.97B | |
-1.44% | 37.16B | |
-3.16% | 35.21B | |
-13.20% | 31B | |
-4.33% | 29.5B | |
+4.60% | 23.5B | |
-17.38% | 20.98B |
- Stock Market
- Equities
- UNIQUEO6 Stock
- Financials Unique Organics Limited